These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26375597)

  • 1. Extremely High Mutation Rate of HIV-1 In Vivo.
    Cuevas JM; Geller R; Garijo R; López-Aldeguer J; Sanjuán R
    PLoS Biol; 2015; 13(9):e1002251. PubMed ID: 26375597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of human immunodeficiency virus type 1 mutational profiles by single-genome amplification after 48-hour propagation in peripheral blood mononuclear cells at different levels of cell activation.
    Russo CT; Alkmim W; Munerato P; Zukurov J; Maricato JT; Sucupira MC; Diaz RS; Janini LM
    Intervirology; 2014; 57(5):277-88. PubMed ID: 24994530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The external domains of the HIV-1 envelope are a mutational cold spot.
    Geller R; Domingo-Calap P; Cuevas JM; Rossolillo P; Negroni M; Sanjuán R
    Nat Commun; 2015 Oct; 6():8571. PubMed ID: 26450412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
    Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
    AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells.
    Kijak GH; Janini LM; Tovanabutra S; Sanders-Buell E; Arroyo MA; Robb ML; Michael NL; Birx DL; McCutchan FE
    Virology; 2008 Jun; 376(1):101-11. PubMed ID: 18436274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection.
    Koulinska IN; Chaplin B; Mwakagile D; Essex M; Renjifo B
    AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1115-23. PubMed ID: 14709248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
    Kieffer TL; Kwon P; Nettles RE; Han Y; Ray SC; Siliciano RF
    J Virol; 2005 Feb; 79(3):1975-80. PubMed ID: 15650227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
    Kaye S; Comber E; Tenant-Flowers M; Loveday C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1221-5. PubMed ID: 8573378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.
    Ojesina AI; Mullins C; Imade G; Samuels J; Sankalé JL; Pam S; Sagay S; Idoko J; Kanki PJ
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1587-92. PubMed ID: 18160018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
    Turner D; Shahar E; Katchman E; Kedem E; Matus N; Katzir M; Hassoun G; Pollack S; Kessner R; Wainberg MA; Avidor B
    J Med Virol; 2009 Sep; 81(9):1509-12. PubMed ID: 19626612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
    Jullaksorn D; Boonchawalit S; Uttiyoung J; Soonthornsata B; Yowang A; Krathong N; Chautrakul S; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression.
    Dalmau J; Rotger M; Erkizia I; Rauch A; Reche P; Pino M; Esteve A; Palou E; Brander C; Paredes R; Phung P; Clotet B; Telenti A; Martinez-Picado J; Prado JG;
    AIDS; 2014 Jun; 28(9):1261-72. PubMed ID: 24732774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
    de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector.
    Rawson JM; Clouser CL; Mansky LM
    Methods Mol Biol; 2016; 1354():71-88. PubMed ID: 26714706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations.
    Telwatte S; Hearps AC; Johnson A; Latham CF; Moore K; Agius P; Tachedjian M; Sonza S; Sluis-Cremer N; Harrigan PR; Tachedjian G
    Nucleic Acids Res; 2015 Mar; 43(6):3256-71. PubMed ID: 25765644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation, fitness, viral diversity, and predictive markers of disease progression in a computational model of HIV type 1 infection.
    Castiglione F; Poccia F; D'Offizi G; Bernaschi M
    AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1314-23. PubMed ID: 15650424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.